LifeSci Capital initiated coverage of Tectonic Therapeutic (TECX) with an Outperform rating and $87 price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECX:
- Tectonic Therapeutic Reports Q1 2025 Financial Results
- Promising Phase 1b Results and Market Potential Drive Buy Rating for Tectonic Therapeutic’s TX45
- Tectonic Therapeutic Announces Phase 1b Trial Results
- Promising Phase 1b Results and Favorable Safety Profile Justify Buy Rating for Tectonic Therapeutic
- Tectonic Therapeutic price target raised to $85 from $51 at Mizuho
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue